nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcipotriol—VDR—parathyroid gland—head and neck cancer	0.0599	0.214	CbGeAlD
Calcipotriol—Skin atrophy—Hydroxyurea—head and neck cancer	0.0479	0.171	CcSEcCtD
Calcipotriol—MPO—saliva—head and neck cancer	0.0474	0.169	CbGeAlD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.0295	0.0677	CbGpPWpGaD
Calcipotriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0284	0.0652	CbGpPWpGaD
Calcipotriol—VDR—hair follicle—head and neck cancer	0.0271	0.0966	CbGeAlD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—RARB—head and neck cancer	0.0263	0.0604	CbGpPWpGaD
Calcipotriol—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.0243	0.0868	CcSEcCtD
Calcipotriol—Skin irritation—Fluorouracil—head and neck cancer	0.0241	0.0859	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0238	0.0546	CbGpPWpGaD
Calcipotriol—Application site pain—Fluorouracil—head and neck cancer	0.0237	0.0845	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors—RARB—head and neck cancer	0.0218	0.05	CbGpPWpGaD
Calcipotriol—CYP24A1—trachea—head and neck cancer	0.0198	0.0708	CbGeAlD
Calcipotriol—VDR—neck—head and neck cancer	0.0182	0.0648	CbGeAlD
Calcipotriol—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.0175	0.0624	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0172	0.0395	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.0167	0.0383	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—CEBPA—head and neck cancer	0.0162	0.0372	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—CCNA1—head and neck cancer	0.0143	0.0327	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0138	0.0493	CcSEcCtD
Calcipotriol—VDR—connective tissue—head and neck cancer	0.013	0.0464	CbGeAlD
Calcipotriol—Tingling sensation—Fluorouracil—head and neck cancer	0.0129	0.0462	CcSEcCtD
Calcipotriol—Stinging—Fluorouracil—head and neck cancer	0.0128	0.0458	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.0126	0.0451	CcSEcCtD
Calcipotriol—VDR—epithelium—head and neck cancer	0.0124	0.0441	CbGeAlD
Calcipotriol—MPO—connective tissue—head and neck cancer	0.011	0.0392	CbGeAlD
Calcipotriol—VDR—trachea—head and neck cancer	0.0109	0.039	CbGeAlD
Calcipotriol—MPO—epithelium—head and neck cancer	0.0104	0.0372	CbGeAlD
Calcipotriol—MPO—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.0102	0.0234	CbGpPWpGaD
Calcipotriol—VDR—lymphoid tissue—head and neck cancer	0.00952	0.034	CbGeAlD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00947	0.0217	CbGpPWpGaD
Calcipotriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00924	0.0212	CbGpPWpGaD
Calcipotriol—CYP24A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00912	0.0209	CbGpPWpGaD
Calcipotriol—VDR—thyroid gland—head and neck cancer	0.00864	0.0308	CbGeAlD
Calcipotriol—CYP24A1—Biological oxidations—NAT2—head and neck cancer	0.0085	0.0195	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TNFRSF10B—head and neck cancer	0.0084	0.0192	CbGpPWpGaD
Calcipotriol—CYP24A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00838	0.0192	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—SOD2—head and neck cancer	0.0083	0.019	CbGpPWpGaD
Calcipotriol—MPO—lymphoid tissue—head and neck cancer	0.00803	0.0286	CbGeAlD
Calcipotriol—MPO—Folate Metabolism—GPX1—head and neck cancer	0.00791	0.0181	CbGpPWpGaD
Calcipotriol—VDR—head—head and neck cancer	0.00767	0.0274	CbGeAlD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.00754	0.0173	CbGpPWpGaD
Calcipotriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00749	0.0172	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Docetaxel—head and neck cancer	0.00717	0.0256	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—TGFA—head and neck cancer	0.00714	0.0164	CbGpPWpGaD
Calcipotriol—Dry skin—Fluorouracil—head and neck cancer	0.00692	0.0247	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL2—head and neck cancer	0.00686	0.0157	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—GSTM1—head and neck cancer	0.00681	0.0156	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00659	0.0151	CbGpPWpGaD
Calcipotriol—MPO—head—head and neck cancer	0.00647	0.0231	CbGeAlD
Calcipotriol—Erythema—Hydroxyurea—head and neck cancer	0.00632	0.0226	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00629	0.0144	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.00598	0.0137	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—STAT3—head and neck cancer	0.00577	0.0132	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.00569	0.013	CbGpPWpGaD
Calcipotriol—VDR—lymph node—head and neck cancer	0.00537	0.0192	CbGeAlD
Calcipotriol—Paraesthesia—Vinblastine—head and neck cancer	0.00508	0.0181	CcSEcCtD
Calcipotriol—Dry skin—Docetaxel—head and neck cancer	0.005	0.0178	CcSEcCtD
Calcipotriol—Pain—Vinblastine—head and neck cancer	0.00484	0.0173	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00455	0.0104	CbGpPWpGaD
Calcipotriol—Erythema—Fluorouracil—head and neck cancer	0.00455	0.0162	CcSEcCtD
Calcipotriol—MPO—lymph node—head and neck cancer	0.00453	0.0162	CbGeAlD
Calcipotriol—Pain—Hydroxyurea—head and neck cancer	0.00441	0.0157	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—IL2—head and neck cancer	0.00432	0.00989	CbGpPWpGaD
Calcipotriol—CYP24A1—Biological oxidations—GSTM1—head and neck cancer	0.0042	0.00962	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Vinblastine—head and neck cancer	0.00417	0.0149	CcSEcCtD
Calcipotriol—CYP24A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00414	0.00949	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—BCL2—head and neck cancer	0.00404	0.00926	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.00403	0.00924	CbGpPWpGaD
Calcipotriol—CYP24A1—Biological oxidations—CYP1A1—head and neck cancer	0.00398	0.00912	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—GPX1—head and neck cancer	0.00397	0.0091	CbGpPWpGaD
Calcipotriol—CYP24A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00393	0.00899	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—PTGS2—head and neck cancer	0.00384	0.0088	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0038	0.0136	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.0037	0.00848	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—BCL2L1—head and neck cancer	0.00351	0.00804	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—UROD—head and neck cancer	0.0035	0.00802	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—CCND1—head and neck cancer	0.00347	0.00795	CbGpPWpGaD
Calcipotriol—Paraesthesia—Fluorouracil—head and neck cancer	0.00333	0.0119	CcSEcCtD
Calcipotriol—Erythema—Docetaxel—head and neck cancer	0.00328	0.0117	CcSEcCtD
Calcipotriol—Rash—Hydroxyurea—head and neck cancer	0.00325	0.0116	CcSEcCtD
Calcipotriol—Dermatitis—Hydroxyurea—head and neck cancer	0.00325	0.0116	CcSEcCtD
Calcipotriol—Pain—Fluorouracil—head and neck cancer	0.00317	0.0113	CcSEcCtD
Calcipotriol—Cholecalciferol—CYP1A1—head and neck cancer	0.00316	1	CrCbGaD
Calcipotriol—VDR—Generic Transcription Pathway—RARB—head and neck cancer	0.00298	0.00682	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—TP53—head and neck cancer	0.00277	0.00635	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Fluorouracil—head and neck cancer	0.00273	0.00976	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00272	0.00622	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00271	0.0062	CbGpPWpGaD
Calcipotriol—Pruritus—Fluorouracil—head and neck cancer	0.00263	0.00938	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—BCL2—head and neck cancer	0.00246	0.00564	CbGpPWpGaD
Calcipotriol—Paraesthesia—Docetaxel—head and neck cancer	0.00241	0.00859	CcSEcCtD
Calcipotriol—Rash—Fluorouracil—head and neck cancer	0.00234	0.00836	CcSEcCtD
Calcipotriol—Dermatitis—Fluorouracil—head and neck cancer	0.00234	0.00835	CcSEcCtD
Calcipotriol—Pain—Docetaxel—head and neck cancer	0.00229	0.00818	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—HRAS—head and neck cancer	0.00219	0.00501	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—PTEN—head and neck cancer	0.00204	0.00467	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Docetaxel—head and neck cancer	0.00197	0.00705	CcSEcCtD
Calcipotriol—Pruritus—Docetaxel—head and neck cancer	0.0019	0.00677	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.00182	0.00417	CbGpPWpGaD
Calcipotriol—Rash—Docetaxel—head and neck cancer	0.00169	0.00603	CcSEcCtD
Calcipotriol—Dermatitis—Docetaxel—head and neck cancer	0.00169	0.00603	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—EGFR—head and neck cancer	0.00166	0.0038	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00154	0.00354	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00153	0.0035	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NAT2—head and neck cancer	0.00145	0.00333	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—RARB—head and neck cancer	0.00143	0.00328	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TP53—head and neck cancer	0.00139	0.00319	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—YAP1—head and neck cancer	0.0013	0.00299	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—DPYD—head and neck cancer	0.00127	0.00292	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00122	0.0028	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—YAP1—head and neck cancer	0.00121	0.00277	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000909	0.00208	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000793	0.00182	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—TYMS—head and neck cancer	0.000726	0.00166	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GSTM1—head and neck cancer	0.000718	0.00165	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GPX1—head and neck cancer	0.000688	0.00158	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CYP1A1—head and neck cancer	0.000681	0.00156	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NOTCH1—head and neck cancer	0.000588	0.00135	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000559	0.00128	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PTGS2—head and neck cancer	0.000405	0.000927	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PTEN—head and neck cancer	0.000353	0.000809	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—MAPK3—head and neck cancer	0.000325	0.000745	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CA—head and neck cancer	0.000249	0.000571	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—AKT1—head and neck cancer	0.000219	0.000502	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—AKT1—head and neck cancer	0.000203	0.000466	CbGpPWpGaD
